title: The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cells.
abstract: The bisdioxopiperazines, including dexrazoxane (ICRF-187), are catalytic or noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce DNA strand breaks. In this study we show that dexrazoxane inhibits the division of Chinese hamster ovary (CHO) cells resulting in marked increases in cell size (up to 80 microm in diameter), volume (up to 150-fold greater), and ploidy (as high as 32N). This last result indicates that the dexrazoxane-induced DNA reduplication was restricted to once per cell cycle. Kinetic analysis of the flow cytometry data indicated that the conversion between successively higher ploidy levels was progressively slowed at longer times of exposure to dexrazoxane. Both the protein and DNA content of dexrazoxane-treated CHO cells increased linearly over time in the same proportion. Light and electron microscopic studies of dexrazoxane-treated cells showed ring-like multilobulated nuclei. Immunohistochemical staining of dexrazoxane-treated cells showed that F-actin and acetylated alpha-tubulin were present in large, highly organized networks. Immunohistochemical staining of the dexrazoxane-treated CHO cells also showed that the topoisomerase II alpha colocalized with the DNA of the multilobulated nuclei. Staining of gamma-tubulin revealed that the dexrazoxane-treated cells contained multiple centrosomes, indicating that dexrazoxane prevents cytokinesis but not centrosome reduplication. It is concluded that dexrazoxane inhibits CHO cytokinesis in cells by virtue of its ability to inhibit topoisomerase II.
authors.affiliation: Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada. B_Hasinoff@UManitoba.CA
authors.forename: B B
authors.initials: BB
authors.lastname: Hasinoff
authors.forename: M E
authors.initials: ME
authors.lastname: Abram
authors.forename: G L
authors.initials: GL
authors.lastname: Chee
authors.forename: E
authors.initials: E
authors.lastname: Huebner
authors.forename: E H
authors.initials: EH
authors.lastname: Byard
authors.forename: N
authors.initials: N
authors.lastname: Barnabé
authors.forename: V J
authors.initials: VJ
authors.lastname: Ferrans
authors.forename: Z X
authors.initials: ZX
authors.lastname: Yu
authors.forename: J C
authors.initials: JC
authors.lastname: Yalowich
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D016466:CHO Cells / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D002384:Catalysis; D002455:Cell Division / Q000187:drug effects; D006224:Cricetinae; D004247:DNA / Q000187:drug effects / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007700:Kinetics; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D011123:Polyploidy; D011929:Razoxane / Q000494:pharmacology*; D059005:Topoisomerase II Inhibitors
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors; D011929:Razoxane; D004247:DNA